A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan

被引：0
|
作者：
Claudia Petereit
Okan Zaba
Ishak Teber
Heike Lüders
Christian Grohé
机构：
[1] Lindenberger Weg 27,ELK Department of Respiratory Diseases
来源：
BMC Pulmonary Medicine | / 13卷
关键词：
Small cell lung cancer (SCLC); Hyponatremia; Syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan
    Petereit, Claudia
    Zaba, Okan
    Teber, Ishak
    Lueders, Heike
    Grohe, Christian
    BMC PULMONARY MEDICINE, 2013, 13
  • [2] The role of tolvaptan in managing hyponatremia in small cell lung cancer patients with SIADH: a retrospective study of 23 cases
    Ren, Peng
    Yang, Qiuan
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (03) : 1229 - 1237
  • [3] Symptomatic therapy of SIADH in small cell lung cancer by tolvaptan
    Schnaiter, A.
    Hiddemann, W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (41) : 2077 - 2079
  • [4] The use of low dose Tolvaptan in the treatment of refractory SIADH in small cell lung cancer
    Ryan, D.
    Casey, R.
    Blazcova, S.
    O'Shea, P.
    Bell, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : 391 - 391
  • [5] SIADH Escape or Tolvaptan Resistance in Progressive Small Cell Lung Cancer
    Mandal, Sunny
    Kannan, Lakshmi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 736 - 736
  • [6] Hyponatraemia secondary to SIADH in small cell lung cancer treated with tolvaptan
    Pothina, N. P.
    Mohammed, K.
    LUNG CANCER, 2013, 79 : S66 - S66
  • [7] Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer
    Irem Bilgetekin
    Ismail Erturk
    Fatma Bugdayci Basal
    Cengiz Karacin
    Nuri Karadurmus
    Berna Oksuzoglu
    Umut Demirci
    International Urology and Nephrology, 2021, 53 : 301 - 307
  • [8] Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer
    Bilgetekin, Irem
    Erturk, Ismail
    Basal, Fatma Bugdayci
    Karacin, Cengiz
    Karadurmus, Nuri
    Oksuzoglu, Berna
    Demirci, Umut
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (02) : 301 - 307
  • [9] Survival analysis in cancer patients with hyponatremia: effectiveness of tolvaptan treatment
    Tomoyuki Kawada
    International Urology and Nephrology, 2022, 54 : 2759 - 2759
  • [10] A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia
    Wu, Ranpu
    Li, Chuling
    Wang, Zimu
    Fan, Hang
    Song, Yong
    Liu, Hongbing
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2469 - 2478
12345